tiprankstipranks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
Company AnnouncementsHengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
3d ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
PremiumCompany Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
3d ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
PremiumCompany Announcements
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
3d ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
PremiumCompany Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
3d ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
PremiumCompany Announcements
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
10d ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
PremiumCompany AnnouncementsJiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
15d ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
Premium
Company Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
15d ago
1276
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
Premium
Company Announcements
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
16d ago
1276
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
PremiumCompany Announcements
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
16d ago
1276
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany Announcements
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
23d ago
1276
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
1M ago
1276
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
1M ago
1276
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
PremiumCompany AnnouncementsHengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
1M ago
1276
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
Premium
Company Announcements
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
1M ago
1276
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
Premium
Company Announcements
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
1M ago
1276
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
PremiumCompany Announcements
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
2M ago
1276
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
PremiumCompany Announcements
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
2M ago
1276
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
PremiumCompany Announcements
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
2M ago
1276
Jiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
PremiumCompany Announcements
Jiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
3M ago
1276
Hengrui Subsidiary Wins NMPA Approval for Innovative Gastric Cancer Biologic
PremiumCompany AnnouncementsHengrui Subsidiary Wins NMPA Approval for Innovative Gastric Cancer Biologic
4M ago
1276
Hengrui Pharma Shareholders Approve Amendments to Articles of Association
Premium
Company Announcements
Hengrui Pharma Shareholders Approve Amendments to Articles of Association
4M ago
1276
Hengrui Pharma Signs 20-Year Licensing Deal and Service Pact with Connected Party Hansoh
Premium
Company Announcements
Hengrui Pharma Signs 20-Year Licensing Deal and Service Pact with Connected Party Hansoh
4M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >